REQUEST FOR LABORATORY DATA Sample Clauses

REQUEST FOR LABORATORY DATA. (a) During the Term, in the event that SmithKline ▇▇▇▇▇▇▇ requests Laboratory Data from Quest Diagnostics and accompanies such request by a written or electronic authorization (an "AUTHORIZATION") granted by a Person with authority to grant SmithKline ▇▇▇▇▇▇▇ access to Laboratory Data (as further provided herein), Quest Diagnostics shall provide, at the fees set forth in Article VIII, SmithKline ▇▇▇▇▇▇▇ or its Affiliates (as applicable) with such Laboratory Data in accordance with the Authorization and the terms and conditions of this Agreement.
View Source
REQUEST FOR LABORATORY DATA. (a) During the Term, in the event that SmithKline ▇▇▇▇▇▇▇ requests Laboratory Data from Quest Diagnostics and accompanies such request by a written or electronic authorization (an "AUTHORIZATION") granted by a Person with authority to grant SmithKline ▇▇▇▇▇▇▇ access to Laboratory Data (as further provided herein), Quest Diagnostics shall provide, at the fees set forth in Article VIII, SmithKline ▇▇▇▇▇▇▇ or its Affiliates (as applicable) with such Laboratory Data in accordance with the Authorization and the terms and conditions of this Agreement. Upon request by Quest Diagnostics, SmithKline ▇▇▇▇▇▇▇ shall, and, if applicable, shall cause its Affiliates to, disclose to Quest Diagnostics the identity of any Third Party to which Laboratory Data (other than Encoded Laboratory Data) provided to SmithKline ▇▇▇▇▇▇▇ under this Agreement is being directly disclosed by SmithKline ▇▇▇▇▇▇▇ or its Affiliates.
View Source

Related to REQUEST FOR LABORATORY DATA

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • Product Information EPIZYME recognizes that by reason of, inter alia, EISAI’s status as an exclusive licensee in the EISAI Territory under this Agreement, EISAI has an interest in EPIZYME’s retention in confidence of certain information of EPIZYME. Accordingly, until the end of all Royalty Term(s) in the EISAI Territory, EPIZYME shall keep confidential, and not publish or otherwise disclose, and not use for any purpose other than to fulfill EPIZYME’s obligations, or exercise EPIZYME’s rights, hereunder any EPIZYME Know-How Controlled by EPIZYME or EPIZYME Collaboration Know-How, in each case that are primarily applicable to EZH2 or EZH2 Compounds (the “Product Information”), except to the extent (a) the Product Information is in the public domain through no fault of EPIZYME, (b) such disclosure or use is expressly permitted under Section 9.3, or (c) such disclosure or use is otherwise expressly permitted by the terms and conditions of this Agreement. For purposes of Section 9.3, each Party shall be deemed to be both the Disclosing Party and the Receiving Party with respect to Product Information. For clarification, the disclosure by EPIZYME to EISAI of Product Information shall not cause such Product Information to cease to be subject to the provisions of this Section 9.2 with respect to the use and disclosure of such Confidential Information by EPIZYME. In the event this Agreement is terminated pursuant to Article 12, this Section 9.2 shall have no continuing force or effect, but the Product Information, to the extent disclosed by EPIZYME to EISAI hereunder, shall continue to be Confidential Information of EPIZYME, subject to the terms of Sections 9.1 and 9.3 for purposes of the surviving provisions of this Agreement. Each Party shall be responsible for compliance by its Affiliates, and its and its Affiliates’ respective officers, directors, employees and agents, with the provisions of Section 9.1 and this Section 9.2.

  • Contractor Selection Justification Form Customers shall complete this Contractor Selection Justification Form for each candidate selected and attach all completed forms to the purchase order. Date: Contractor’s Name: _ Contractor’s Contact Information: Address: _ Phone: _ Email: Candidate’s Name: _ Date Candidate will be available: _ Hourly rate of candidate: $ Position candidate recommended for: _ Justification for selection of candidate: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Agency: Division/Section/Unit: _ Printed Name: _ Title: _ Signature _ Date: Contractor's Name: Quarter: Purchase Order (PO) Number: PO Total $ Amount: PO Starting Date Ending Date Please review the attached Rating Definitions and provide your opinion by rating the following:

  • Technology Research Analyst Job# 1810 General Characteristics

  • New Application for Licensure Any time after the three-month period has lapsed from the Effective Date of this Agreement and Respondent has paid the Administrative Penalty set forth in Section III, Paragraph 1 of this Order, Respondent may apply for a new mortgage loan originator license or, as applicable, petition for the reinstatement of an MLO Activity Endorsement in any or all of the Participating States with the understanding that each State Mortgage Regulator reserves the rights to fully investigate such application for licensure or petition for reinstatement of an MLO Activity Endorsement and may either approve or deny such application or petition pursuant to the normal process for such licensing or endorsement investigations. No license application or petition described in this paragraph will be denied solely based on the facts, circumstances, or consensual resolution provided for in this Agreement. Respondent further agrees that Respondent must satisfy the Administrative Penalty provision prior to submitting an application for a new mortgage loan originator license or, as applicable, petition for the reinstatement of an MLO Activity Endorsement.